Junji Morimoto

1.2k total citations
55 papers, 1.0k citations indexed

About

Junji Morimoto is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Junji Morimoto has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Genetics and 16 papers in Oncology. Recurrent topics in Junji Morimoto's work include Virus-based gene therapy research (11 papers), Microbial Inactivation Methods (7 papers) and Angiogenesis and VEGF in Cancer (6 papers). Junji Morimoto is often cited by papers focused on Virus-based gene therapy research (11 papers), Microbial Inactivation Methods (7 papers) and Angiogenesis and VEGF in Cancer (6 papers). Junji Morimoto collaborates with scholars based in Japan, United States and Netherlands. Junji Morimoto's co-authors include Yoshinori Otsuki, Masaaki Shibata, Shunsuke Imai, Yukihiro Akao, Munekazu Iinuma, Eiko Shibata, Seiichi Suzuki, Kanako Akamatsu, Äkïhïko Okuyama and Haruhito Azuma and has published in prestigious journals such as International Journal of Cancer, Life Sciences and Cancer Letters.

In The Last Decade

Junji Morimoto

53 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Morimoto Japan 17 562 228 175 145 135 55 1.0k
Xiangrong Cao China 15 553 1.0× 353 1.5× 69 0.4× 151 1.0× 54 0.4× 43 926
Margaret M. Kasten United States 14 1.2k 2.2× 317 1.4× 151 0.9× 85 0.6× 50 0.4× 17 1.5k
John P. Alao Sweden 18 1.0k 1.9× 435 1.9× 91 0.5× 131 0.9× 103 0.8× 33 1.6k
T Toge Japan 21 538 1.0× 531 2.3× 64 0.4× 132 0.9× 44 0.3× 97 1.4k
Sivaprakasam Balasubramanian United States 21 817 1.5× 261 1.1× 62 0.4× 54 0.4× 109 0.8× 30 1.4k
Yanliang Lin China 21 532 0.9× 151 0.7× 113 0.6× 38 0.3× 154 1.1× 48 1.1k
Kazuko Sakamoto United States 12 237 0.4× 350 1.5× 122 0.7× 102 0.7× 157 1.2× 15 960
Haiming Ding United States 15 514 0.9× 162 0.7× 95 0.5× 88 0.6× 100 0.7× 30 898
M Oshimura Japan 9 945 1.7× 265 1.2× 41 0.2× 126 0.9× 59 0.4× 11 1.4k
Michael F. Callaham United States 13 684 1.2× 166 0.7× 52 0.3× 150 1.0× 41 0.3× 23 999

Countries citing papers authored by Junji Morimoto

Since Specialization
Citations

This map shows the geographic impact of Junji Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Morimoto more than expected).

Fields of papers citing papers by Junji Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Morimoto. The network helps show where Junji Morimoto may publish in the future.

Co-authorship network of co-authors of Junji Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Morimoto. A scholar is included among the top collaborators of Junji Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Morimoto. Junji Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shibata, Masaaki, Eiko Shibata, Junji Morimoto, & Yoichi Kondo. (2020). Urethane-induced Mammary Carcinogenesis Susceptibility in Transgenic Mice Expressing a Dominant-negative TGF-β Type II Receptor. Anticancer Research. 40(5). 2687–2694. 1 indexed citations
2.
3.
Shibata, Masaaki, Junji Morimoto, Eiko Shibata, et al.. (2010). Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer. BMC Cancer. 10(1). 566–566. 14 indexed citations
4.
Shibata, Masaaki, Jayakrishna Ambati, Eiko Shibata, et al.. (2010). The endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model. BMC Medicine. 8(1). 69–69. 16 indexed citations
5.
Shibata, Masaaki, Junji Morimoto, Kanako Akamatsu, & Yoshinori Otsuki. (2008). Antimetastatic effect of suicide gene therapy for mouse mammary cancers requires T-cell-mediated immune responses. Medical Molecular Morphology. 41(1). 34–43. 5 indexed citations
6.
7.
Shibata, Masaaki, Yoshihiro Miwa, Minoru Miyashita, et al.. (2005). Electrogene transfer of an Epstein–Barr virus‐based plasmid replicon vector containing the diphtheria toxin A gene suppresses mammary carcinoma growth in SCID mice. Cancer Science. 96(7). 434–440. 9 indexed citations
8.
Shibata, Masaaki, et al.. (2002). Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation. Cancer Gene Therapy. 9(1). 16–27. 4 indexed citations
9.
Shibata, Masaaki, et al.. (2002). Massive apoptotic cell death in chemically induced rat urinary bladder carcinomas following in situ HSVtk electrogene transfer. The Journal of Gene Medicine. 5(3). 219–231. 23 indexed citations
10.
Hiroishi, Shingo, et al.. (2001). Antitumor effects of Marginisporum crassissimum (Rhodophyceae), a marine red alga. Cancer Letters. 167(2). 145–150. 24 indexed citations
11.
Hiroishi, Shingo, et al.. (1998). Toxicity of Bloom-forming blue-green Algae.. NIPPON SUISAN GAKKAISHI. 64(2). 295–296. 3 indexed citations
12.
Kiyozuka, Yasuhiko, Akira Asai, H Senzaki, et al.. (1998). Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression.. International Journal of Molecular Medicine. 2(4). 437–44. 5 indexed citations
13.
Hiroishi, Shingo, et al.. (1995). Multiple metastases of mammary carcinoma cell lines isolated from feral mouse. Cancer Letters. 92(1). 83–86. 7 indexed citations
14.
Yamashita, Mariko, et al.. (1992). Milk cream does not enhance 2,7-dimethylbenz[a]anthracene-induced mammary tumorigenesis. Cancer Letters. 61(2). 141–145. 8 indexed citations
15.
Hiasa, Y, et al.. (1992). Carcinogenicity study in rats of phytic acid ‘Daiichi’, a natural food additive. Food and Chemical Toxicology. 30(2). 117–125. 19 indexed citations
16.
Morimoto, Junji, et al.. (1991). Highly Metastatic Mammary Tumors in <I>M. m. musculus</I> Sub-Jyg (JYG mouse). EXPERIMENTAL ANIMALS. 40(2). 245–249. 2 indexed citations
17.
Kiyozuka, Yasuhiko, et al.. (1988). Establishment and characterization of human ovarian serous cystadenocarcinoma cell line(SHIN-3) which produces CA 125 and TPA in vitro.. The Journal of the Japanese Society of Clinical Cytology. 27(6). 926–935. 5 indexed citations
18.
Morimoto, Junji, et al.. (1987). Establishment and characterization of a new murine mammary tumor cell line, balb/c-MC. In Vitro Cellular & Developmental Biology - Plant. 23(11). 755–758. 10 indexed citations
19.
Morimoto, Junji, et al.. (1986). Chronic toxicity test of KCl and NaCl in F344/S1c rats.. 37(2). 115–127. 1 indexed citations
20.
Imai, Shunsuke, et al.. (1980). Mammary tumor virus antigen expression in inbred mouse strains of European origin established in Japan.. PubMed. 71(4). 419–24. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangrong Cao Breakdown of academic impact, for papers by Margaret M. Kasten Breakdown of academic impact, for papers by John P. Alao Breakdown of academic impact, for papers by T Toge Breakdown of academic impact, for papers by Sivaprakasam Balasubramanian Breakdown of academic impact, for papers by Yanliang Lin Breakdown of academic impact, for papers by Kazuko Sakamoto Breakdown of academic impact, for papers by Haiming Ding Breakdown of academic impact, for papers by M Oshimura Breakdown of academic impact, for papers by Michael F. Callaham
Rankless by CCL
2026